ROSATOM opens a new front in fight against cancer

Press release
Published September 27th, 2016 - 06:47 GMT
ROSATOM opens a new front in fight against cancer
ROSATOM opens a new front in fight against cancer

Federal Service for Surveillance in Healthcare (Roszdravnadzor) issued the registration certificate for production of domestic micro sources with the radioactive isotope iodine-125 for brachytherapy operations for cancer treatment for State Scientific Center of Russian Federation – Institute for Physics and Power Engineering Named after A. I. Leypunsky (part of the research division of ROSATOM).

"ROSATOM has made another step in the development of nuclear medicine, bringing a new medication to mass production. It is real help for people with cancer and we will develop this direction. Besides, micro-sources for brachytherapy is a competitive product that can enter the international market "- said Vyacheslav Pershukov, Deputy Director General - Director of the Innovations Management Unit of State Corporation ROSATOM.

“It is pure import substitution. Now we have the right to deliver our products to oncology centers, public and private clinics, etc. for the price several times cheaper than foreign analogues. There is a lot of work for the growth of production – increasing of work-shifts, involvement of all equipment, and we have all the resources to do this”, said General Director of SSC RF – IPPE Andrew Goverdovsky.

Currently, the experts of the SSC RF – IPPE in collaboration with physicians, develop approaches for a slight change in nomenclature, so that not only brachytherapy of the prostate but also other organs.

For reference:

Brachytherapy — a type of radiation therapy of cancer of the prostate. In the course of medical procedures specifically calculated dose of radiation is delivered directly to the tumor without damaging the surrounding tissues and organs. The brachytherapy, typically performed on an outpatient basis or with the patient's stay in the hospital for several days. The majority of patients after brachytherapy is not faced with the recurrence of the disease within an average of 10 years. The first operation in brachytherapy of malignant tumors of the prostate using completely Russian micro-sources of the isotope iodine-125 took place on 9 October 2015 at the Medical radiological research center. A. F. Tsyb (Obninsk), the branch of the Federal State Budget Institution "National Medical Research Radiological Center" of  Russian Ministry of health.

Isotope iodine-125 is produced in the Research Institute of Atomic Reactors of SC ROSATOM (RIAR, Dimitrovgrad) in the required quantities, micro-sources with the isotope are made in IPPE. Basics of the project were established about 10 years ago, as the result domestic high-tech product was obtained that also has significant export potential. State Scientific Center of Russian Federation – Institute for Physics and Power Engineering Named after A. I. Leypunsky is situated in Obninsk city. Obninsk is the world leader in the area of use of liquid metals as heat transfer agents in NPPs with fast reactors, marine and space nuclear power plants. Institute’s works in the sphere of nuclear physics, nuclear Power Technologies and nuclear security won global recognition. Experimental researches in areas of nuclear-laser physics and plasma physics, radiative study of materials, Radiochemistry and new high-end technologies including nanotechnologies, hydrogen energy and nuclear medicine technologies are held in State Scientific Center of Russian Federation – Institute for Physics and Power Engineering.


Background Information


The State Atomic Energy Corporation ROSATOM is one of the global technological leaders. The company has assets and competencies to work at all stages of the nuclear production chain from uranium mining to decommissioning of nuclear facilities and spent nuclear fuel management.ROSATOM brings together about 400 enterprises and organizations, including the world's only nuclear icebreaker fleet. It is the largest electricity generating company in Russia, accounting for 18.7% of the country’s total generation of electricity. ROSATOM is the third in the world in nuclear power generation.The corporation is the global leader in simultaneous implementation of NPP power units and has the largest portfolio of foreign construction projects (36 NPP units in 12 countries). ROSATOM manufactures equipment and produces isotopes for nuclear medicine, carries out research and material studies. It also assembles supercomputers and designs software as well as different nuclear and non-nuclear innovative products. The company has business ventures covering various clean energy projects, including wind energy. ROSATOM has second largest uranium reserves and 17% of the global nuclear fuel market.

للسبت الـ15.. احتجاجات السترات الصفراء تتواصل في فرنسا

Published February 23rd, 2019 - 09:46 GMT
من احتجاجات السترات الصفراء في فرنسا
من احتجاجات السترات الصفراء في فرنسا

يواصل الآلاف من محتجي حركة "السترات الصفراء" تظاهراتهم للأسبوع الخامس عشر على التوالي في العاصمة باريس ومدن فرنسية أخرى.

وقالت الشرطة في بيان، "أعلن في باريس عن خمس تظاهرات، ثلاث منها بشكل تجمعات، أما المسيرتان الأخريان اللتان سميتا على موقع فيسبوك للتواصل الاجتماعي "تسونامي أصفر" و"كلنا في الشانزيليزيه لا نتراجع عن شيء"، فستنطلقان من قوس النصر ظهر اليوم السبت على التوالي وتنتهيان في ساحة تروكاديرو".

وأضاف البيان أن هذه المسيرات ستعبر جادة الشانزليزيه وحي الأوبرا وتلتف حول متحف اللوفر وتتوقف أمام مقر "حركة شركات فرنسا" ثم تواصل طريقها إلى ساحة تروكاديرو.

من جهتها قالت وزارة الداخلية الفرنسية بشان الأرقام التي تنشرها، إن حجم التظاهرات تراجع في أيام السبوت الأربعة الأخيرة.

بدورهم أعلن أربعة آلاف شخص من رواد مواقع التواصل الاجتماعي مساء الجمعة عبر فيسبوك عن نيتهم المشاركة في هذه التجمعات، وقال أكثر من 18 ألفا آخرين إنهم "مهتمون" بها.

وذكرت مواقع التواصل أنه ستُنظم تجمعات في مدن أخرى غير العاصمة، مثل بوردو، التي تعد مع تولوز من مواقع التعبئة الكبرى التي تشهد باستمرار صدامات عنيفة مع قوات الشرطة.

من جهتها أبلغت نقابة شرطة بوردو المسؤولين مساء الجمعة عن "الوضع الحرج" و"الإنهاك المعنوي والجسدي" لرجال الشرطة، مطالبة بوسائل أكثر فاعلية لمواجهة "حرب العصابات في المدن".

لكن وزير الداخلية الفرنسي كريستوف كاستانير صرح خلال زيارة إلى ضاحية أوبرفيلييه شمال شرقي باريس "إذا كان البعض يعتقدون أن رجال الشرطة سينهكون وسيتم استنزافهم، فهم مخطئون"، مؤكدا أن "رجال الشرطة سيكونون حاضرين وسيقومون بمهامهم".

يشار إلى أن 41 ألف شخص تظاهروا في فرنسا السبت الماضي، مقابل 282 ألفا في 17 نوفمبر أول يوم للتحركات الاحتجاجية الاجتماعية، بحسب بيانات رسمية

© 2000 - 2019 Al Bawaba (

You may also like

PR Contact

Contact Name
Mohammed Khalaf
Contact email

Previous PR’s

PR Rates

Buy credits to publish your articles on Al Bawaba Biz here

You May Also Like


Sign up to our newsletter for exclusive updates and enhanced content